A detailed history of Crewe Advisors LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Crewe Advisors LLC holds 110 shares of TWST stock, worth $5,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Holding current value
$5,929
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$32.28 - $41.5 $3,550 - $4,565
110 New
110 $3,000
Q3 2022

Nov 14, 2022

BUY
$33.44 - $56.56 $1,337 - $2,262
40 Added 48.19%
123 $4,000
Q2 2022

Aug 02, 2022

BUY
$26.2 - $54.0 $2,174 - $4,482
83 New
83 $3,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $3.04B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.